Search Within

Anita Kumar

Formats
  1. Meeting Abstract (98)
  2. Journal Article (63)
  3. Review (7)
  4. Book Section (6)
  5. Research Letter (4)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (180)
  2. Department of Medicine (180)
  3. Hematologic Malignancies, Division of (180)
  4. Lymphoma (180)
  5. Survivorship Research (100)
  6. Population Sciences Research Program (91)

More Groups

People
  1. Andrew Zelenetz (123)
  2. Paul Hamlin (94)
  3. Alison Moskowitz (93)
  4. Ariela Noy (93)
  5. Maria Palomba (87)
  6. Steven Horwitz (87)

More People

Years
  1. 2025 (4)
  2. 2024 (19)
  3. 2023 (32)
  4. 2022 (12)
  5. 2021 (24)
  6. 2020 (17)

More Years

Publications
  1. Blood (70)
  2. Hematological Oncology (19)
  3. Journal of Clinical Oncology (12)
  4. Blood Advances (11)
  5. Haematologica (9)
  6. Leukemia and Lymphoma (7)

More Publications

Publishers
  1. American Society of Hematology (82)
  2. Wiley Blackwell (19)
  3. American Society of Clinical Oncology (12)
  4. Nature Publishing Group (10)
  5. Ferrata Storti Foundation (9)
  6. Taylor & Francis Group (8)

More Publishers

Results (180)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD8(+) T cells contribute to survival in patients with COVID-19 and hematologic cancer
    Journal Article

    Bange, E. M.; Han, N. A.; Wileyto, P.; Kim, J. Y.; Gouma, S.; Robinson, J.; Greenplate, A. R.; Hwee, M. A.; Porterfield, F.; Owoyemi, O.; more...
    Nature Medicine (2021)

    Fulltext@MSK | Save
  • Role of maintenance rituximab after first‐line bendamustine + rituximab or R‐CHOP in patients with mantle cell lymphoma from a large US real‐world cohort
    Meeting Abstract

    Wang, M.; Salles, G.; Kumar, A.; Qi, K.; Daly, K.; Parisi, L.; Zhu, A.; Martin, P.
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Real‐world treatment patterns and outcomes of 3455 previously untreated mantle cell lymphoma patients in US routine clinical practice
    Meeting Abstract

    Kumar, A.; Martin, P.; Wang, M.; Qi, K.; Daly, K.; Parisi, L.; Zhu, A.; Salles, G.
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • The combination of duvelisib and romidepsin (DR) is highly active against relapsed/refractory peripheral T‐cell lymphoma with low rates of transaminitis: Final results
    Meeting Abstract

    Horwitz, S. M.; Moskowitz, A. J.; Mehta‐Shah, N.; Jacobsen, E. D.; Khodadoust, M. S.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Myskowski, P.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Time to second line Bruton tyrosine kinase therapy and age at its initiation are strongly associated with subsequent overall survival in patients with first relapse of mantle cell lymphoma
    Meeting Abstract

    Villa, D.; Jiang, A.; Crosbie, N.; Rule, S.; McCulloch, R.; Visco, C.; Buege, M. J.; Kumar, A.; Bond, D.; Paludo, J.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Phase I study of bendamustine, rituximab, ibrutinib, and venetoclax in relapsed, refractory mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Batlevi, C.; Drullinsky, P.; Grieve, C.; Laraque, L.; Joseph, A.; Mahajan, N.; Matasar, M.; Straus, D.; Zelenetz, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Clinical outcomes and the role of observation in early‐stage follicular lymphoma
    Meeting Abstract

    Sha, F.; Okwali, M.; Alperovich, A.; Caron, P. C.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Kumar, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
    Journal Article

    Bobillo, S.; Joffe, E.; Sermer, D.; Mondello, P.; Ghione, P.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Kumar, A.; more...
    Blood Cancer Journal (2021)

    Fulltext@MSK | Save
  • Noninvasive monitoring of mantle cell lymphoma by immunoglobulin gene next-generation sequencing in a phase 2 study of sequential chemoradioimmunotherapy followed by autologous stem-cell rescue
    Journal Article

    Kumar, A.; Bantilan, K. S.; Jacob, A. P.; Park, A.; Schoninger, S. F.; Sauter, C.; Ulaner, G. A.; Casulo, C.; Faham, M.; Kong, K. A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue
    Journal Article

    Joffe, E.; Leyfman, Y.; Drill, E.; Rajeeve, S.; Zelenetz, A. D.; Lia Palomba, M.; Moskowitz, C. H.; Portlock, C.; Noy, A.; Horwitz, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save